| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 2.34e-06 | 10 | 55 | 3 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 2.34e-06 | 10 | 55 | 3 | GO:0102033 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 7.45e-06 | 2 | 55 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 7.45e-06 | 2 | 55 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor activity | 2.23e-05 | 3 | 55 | 2 | GO:0005017 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 5.52e-05 | 27 | 55 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor binding | 1.11e-04 | 6 | 55 | 2 | GO:0038085 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.22e-04 | 35 | 55 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.55e-04 | 7 | 55 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.55e-04 | 7 | 55 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 2.26e-04 | 43 | 55 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 3.31e-04 | 10 | 55 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 3.33e-04 | 49 | 55 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 4.83e-04 | 12 | 55 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 5.70e-04 | 13 | 55 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate binding | 7.64e-04 | 15 | 55 | 2 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 8.72e-04 | 16 | 55 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 8.72e-04 | 16 | 55 | 2 | GO:0050543 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor binding | 9.87e-04 | 17 | 55 | 2 | GO:0005161 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.08e-03 | 164 | 55 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.82e-03 | 23 | 55 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.98e-03 | 24 | 55 | 2 | GO:0008392 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 2.69e-03 | 28 | 55 | 2 | GO:0036041 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 3.93e-03 | 115 | 55 | 3 | GO:0004497 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.18e-03 | 127 | 55 | 3 | GO:0016616 | |
| GeneOntologyMolecularFunction | histone binding | 6.09e-03 | 265 | 55 | 4 | GO:0042393 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 6.52e-03 | 138 | 55 | 3 | GO:0016614 | |
| GeneOntologyMolecularFunction | heme binding | 8.80e-03 | 154 | 55 | 3 | GO:0020037 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 6.76e-06 | 14 | 56 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus morphogenesis | 2.17e-05 | 3 | 56 | 2 | GO:0072275 | |
| GeneOntologyBiologicalProcess | metanephric glomerular capillary formation | 2.17e-05 | 3 | 56 | 2 | GO:0072277 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus vasculature morphogenesis | 2.17e-05 | 3 | 56 | 2 | GO:0072276 | |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 2.17e-05 | 3 | 56 | 2 | GO:0048252 | |
| GeneOntologyBiologicalProcess | VEGF-activated platelet-derived growth factor receptor signaling pathway | 2.17e-05 | 3 | 56 | 2 | GO:0038086 | |
| GeneOntologyBiologicalProcess | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway | 2.17e-05 | 3 | 56 | 2 | GO:0038091 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 3.49e-05 | 68 | 56 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 4.15e-05 | 142 | 56 | 5 | GO:0006690 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 7.31e-05 | 30 | 56 | 3 | GO:0072012 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 8.07e-05 | 31 | 56 | 3 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 8.07e-05 | 31 | 56 | 3 | GO:0061437 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 1.08e-04 | 6 | 56 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 1.08e-04 | 6 | 56 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 1.51e-04 | 7 | 56 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 1.51e-04 | 7 | 56 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus vasculature development | 2.01e-04 | 8 | 56 | 2 | GO:0072239 | |
| GeneOntologyBiologicalProcess | lung growth | 2.01e-04 | 8 | 56 | 2 | GO:0060437 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 2.57e-04 | 9 | 56 | 2 | GO:0002933 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 2.67e-04 | 211 | 56 | 5 | GO:0060041 | |
| GeneOntologyBiologicalProcess | camera-type eye photoreceptor cell differentiation | 3.20e-04 | 49 | 56 | 3 | GO:0060219 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 3.59e-04 | 124 | 56 | 4 | GO:0001676 | |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 3.92e-04 | 11 | 56 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 4.05e-04 | 128 | 56 | 4 | GO:0033559 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | 4.52e-04 | 676 | 56 | 8 | GO:0044283 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 4.55e-04 | 132 | 56 | 4 | GO:0055006 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | 5.16e-04 | 374 | 56 | 6 | GO:0046394 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | 5.38e-04 | 377 | 56 | 6 | GO:0016053 | |
| GeneOntologyBiologicalProcess | regulation of Ras protein signal transduction | 6.10e-04 | 61 | 56 | 3 | GO:0046578 | |
| GeneOntologyBiologicalProcess | muscle cell development | 6.80e-04 | 259 | 56 | 5 | GO:0055001 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus development | 7.43e-04 | 15 | 56 | 2 | GO:0072224 | |
| GeneOntologyBiologicalProcess | medium-chain fatty acid metabolic process | 7.43e-04 | 15 | 56 | 2 | GO:0051791 | |
| GeneOntologyBiologicalProcess | icosanoid biosynthetic process | 8.03e-04 | 67 | 56 | 3 | GO:0046456 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.75e-04 | 487 | 55 | 7 | GO:0016324 | |
| MousePheno | abnormal renal transport | 8.68e-07 | 23 | 46 | 4 | MP:0011417 | |
| MousePheno | abnormal renal sodium ion transport | 1.85e-06 | 8 | 46 | 3 | MP:0011442 | |
| MousePheno | increased renal vascular resistance | 1.05e-04 | 5 | 46 | 2 | MP:0005531 | |
| MousePheno | abnormal renal sodium reabsorption | 1.05e-04 | 5 | 46 | 2 | MP:0010109 | |
| MousePheno | abnormal cranial neural crest cell morphology | 1.58e-04 | 6 | 46 | 2 | MP:0012754 | |
| Domain | - | 2.55e-05 | 3 | 55 | 2 | 4.10.1130.10 | |
| Domain | Tyr_kinase_CSF1/PDGF_rcpt | 1.27e-04 | 6 | 55 | 2 | IPR016243 | |
| Domain | Tyr_kinase_rcpt_3_CS | 2.36e-04 | 8 | 55 | 2 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 2.36e-04 | 8 | 55 | 2 | PS00240 | |
| Domain | BTK | 3.02e-04 | 9 | 55 | 2 | SM00107 | |
| Domain | Znf_Btk_motif | 3.02e-04 | 9 | 55 | 2 | IPR001562 | |
| Domain | BTK | 3.02e-04 | 9 | 55 | 2 | PF00779 | |
| Domain | ZF_BTK | 3.02e-04 | 9 | 55 | 2 | PS51113 | |
| Domain | Cyt_P450_E_grp-I | 3.14e-04 | 45 | 55 | 3 | IPR002401 | |
| Domain | Cyt_P450_CS | 5.10e-04 | 53 | 55 | 3 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 6.32e-04 | 57 | 55 | 3 | PS00086 | |
| Domain | - | 6.65e-04 | 58 | 55 | 3 | 1.10.630.10 | |
| Domain | p450 | 6.65e-04 | 58 | 55 | 3 | PF00067 | |
| Domain | Cyt_P450 | 7.34e-04 | 60 | 55 | 3 | IPR001128 | |
| Domain | RasGAP | 7.57e-04 | 14 | 55 | 2 | SM00323 | |
| Domain | RasGAP_CS | 7.57e-04 | 14 | 55 | 2 | IPR023152 | |
| Domain | RasGAP | 8.72e-04 | 15 | 55 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 8.72e-04 | 15 | 55 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 8.72e-04 | 15 | 55 | 2 | PS50018 | |
| Domain | - | 9.95e-04 | 16 | 55 | 2 | 1.10.506.10 | |
| Domain | RasGAP_dom | 1.26e-03 | 18 | 55 | 2 | IPR001936 | |
| Domain | PROTEIN_KINASE_TYR | 2.93e-03 | 97 | 55 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.93e-03 | 97 | 55 | 3 | IPR008266 | |
| Domain | - | 4.76e-03 | 35 | 55 | 2 | 3.20.20.80 | |
| Domain | Kinase-like_dom | 5.05e-03 | 542 | 55 | 6 | IPR011009 | |
| Domain | Glyco_hydro_catalytic_dom | 5.59e-03 | 38 | 55 | 2 | IPR013781 | |
| Domain | - | 5.78e-03 | 391 | 55 | 5 | 2.30.29.30 | |
| Domain | PH_dom-like | 8.23e-03 | 426 | 55 | 5 | IPR011993 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 2.04e-06 | 9 | 42 | 3 | M39344 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 3.99e-06 | 11 | 42 | 3 | MM14863 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 3.99e-06 | 11 | 42 | 3 | M47812 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 6.89e-06 | 13 | 42 | 3 | M47398 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 4.32e-05 | 219 | 42 | 6 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 4.43e-05 | 220 | 42 | 6 | M10320 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 1.10e-04 | 84 | 42 | 4 | M39839 | |
| Pathway | WP_RAS_SIGNALING | 2.06e-04 | 184 | 42 | 5 | M39764 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.52e-04 | 104 | 42 | 4 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.62e-04 | 105 | 42 | 4 | MM14842 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 3.08e-04 | 9 | 42 | 2 | M27143 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 3.08e-04 | 9 | 42 | 2 | M39819 | |
| Pathway | WP_OSTEOBLAST_SIGNALING | 3.84e-04 | 10 | 42 | 2 | MM15862 | |
| Pathway | REACTOME_EICOSANOIDS | 5.61e-04 | 12 | 42 | 2 | M27129 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 5.61e-04 | 12 | 42 | 2 | M27128 | |
| Pathway | REACTOME_EICOSANOIDS | 5.61e-04 | 12 | 42 | 2 | MM14845 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 6.77e-04 | 58 | 42 | 3 | M5410 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 7.12e-04 | 59 | 42 | 3 | M27140 | |
| Pathway | WP_OSTEOBLAST_SIGNALING | 7.71e-04 | 14 | 42 | 2 | M39599 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 7.71e-04 | 14 | 42 | 2 | MM15842 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 7.85e-04 | 61 | 42 | 3 | MM14861 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 8.23e-04 | 62 | 42 | 3 | M39653 | |
| Pathway | WP_MALE_INFERTILITY | 8.87e-04 | 145 | 42 | 4 | M39856 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 8.88e-04 | 15 | 42 | 2 | M39717 | |
| Pathway | REACTOME_FATTY_ACIDS | 8.88e-04 | 15 | 42 | 2 | M27126 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 8.88e-04 | 15 | 42 | 2 | M47535 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 9.03e-04 | 64 | 42 | 3 | M5650 | |
| Pathway | KEGG_RETINOL_METABOLISM | 9.03e-04 | 64 | 42 | 3 | M9488 | |
| Pathway | KEGG_GLIOMA | 9.45e-04 | 65 | 42 | 3 | M1835 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 9.88e-04 | 66 | 42 | 3 | MM14839 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.15e-03 | 17 | 42 | 2 | M47387 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.15e-03 | 17 | 42 | 2 | M47376 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.29e-03 | 18 | 42 | 2 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.29e-03 | 18 | 42 | 2 | MM14841 | |
| Pathway | WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA | 1.59e-03 | 20 | 42 | 2 | M39381 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 1.76e-03 | 21 | 42 | 2 | M8601 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.76e-03 | 21 | 42 | 2 | M27137 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 1.76e-03 | 21 | 42 | 2 | MM1463 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 1.91e-03 | 83 | 42 | 3 | M27163 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 2.43e-03 | 318 | 42 | 5 | MM15278 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.49e-03 | 25 | 42 | 2 | MM14858 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 2.49e-03 | 25 | 42 | 2 | M47934 | |
| Pubmed | The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. | 4.17e-09 | 3 | 57 | 3 | 1991046 | |
| Pubmed | Three-axis classification of mouse lung mesenchymal cells reveals two populations of myofibroblasts. | 1.45e-07 | 7 | 57 | 3 | 35302583 | |
| Pubmed | Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. | 2.32e-07 | 8 | 57 | 3 | 18488193 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 1.72e-06 | 351 | 57 | 7 | 20453000 | |
| Pubmed | Calcium signaling induces partial EMT and renal fibrosis in a Wnt4mCherry knock-in mouse model. | 1.79e-06 | 53 | 57 | 4 | 38653356 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15611369 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19333949 | ||
| Pubmed | The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradation. | 2.64e-06 | 2 | 57 | 2 | 19644140 | |
| Pubmed | Platelet-derived growth factor receptor expression and activation in choroid plexus tumors. | 2.64e-06 | 2 | 57 | 2 | 19717644 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 8586421 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 11544480 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 7523122 | ||
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 2.64e-06 | 2 | 57 | 2 | 11448776 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17344284 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20489144 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17526865 | ||
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 2.64e-06 | 2 | 57 | 2 | 23641057 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 1847074 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15059936 | ||
| Pubmed | Platelet-derived growth factor receptor: current views of the two-subunit model. | 2.64e-06 | 2 | 57 | 2 | 2161888 | |
| Pubmed | Roles of platelet-derived growth factor in the developing and mature nervous systems. | 2.64e-06 | 2 | 57 | 2 | 9233543 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 18331602 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 28912346 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 24413902 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 28129672 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 14624252 | ||
| Pubmed | PDGF receptors in tumor biology: prognostic and predictive potential. | 2.64e-06 | 2 | 57 | 2 | 25145436 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19035305 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 8617789 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 8031839 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 7665222 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 10860550 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 2554309 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 2531695 | ||
| Pubmed | Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer. | 2.64e-06 | 2 | 57 | 2 | 27248825 | |
| Pubmed | Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo. | 2.64e-06 | 2 | 57 | 2 | 18815281 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19839721 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 2542288 | ||
| Pubmed | Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. | 2.64e-06 | 2 | 57 | 2 | 11320253 | |
| Pubmed | Characterization of the CYP4A11 gene, a second CYP4A gene in humans. | 2.64e-06 | 2 | 57 | 2 | 12464262 | |
| Pubmed | Postnatal tendon growth and remodeling require platelet-derived growth factor receptor signaling. | 2.64e-06 | 2 | 57 | 2 | 29341790 | |
| Pubmed | Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta. | 2.64e-06 | 2 | 57 | 2 | 15066132 | |
| Pubmed | Autocrine PDGFR signaling promotes mammary cancer metastasis. | 2.64e-06 | 2 | 57 | 2 | 16741576 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15380338 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17363728 | ||
| Pubmed | Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer. | 2.64e-06 | 2 | 57 | 2 | 19115205 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 23825080 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17145809 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 16691295 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19843560 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 3829886 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 32737331 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 22431518 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 11782318 | ||
| Pubmed | Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice. | 2.64e-06 | 2 | 57 | 2 | 29277328 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 21820496 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 22661233 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20107158 | ||
| Pubmed | Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. | 2.64e-06 | 2 | 57 | 2 | 20943934 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 18288404 | ||
| Pubmed | Calcitriol inhibits growth response to Platelet-Derived Growth Factor-BB in human prostate cells. | 2.64e-06 | 2 | 57 | 2 | 15862965 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 22697462 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 2766933 | ||
| Pubmed | A new look at platelet-derived growth factor in renal disease. | 2.64e-06 | 2 | 57 | 2 | 18077793 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 11471167 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 24763086 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17448020 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17112342 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 16041389 | ||
| Pubmed | Different PDGF Receptor Dimers Drive Distinct Migration Modes of the Mouse Skin Fibroblast. | 2.64e-06 | 2 | 57 | 2 | 30485861 | |
| Pubmed | Platelet-derived growth factor receptor expression and amplification in choroid plexus carcinomas. | 2.64e-06 | 2 | 57 | 2 | 18157090 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20886582 | ||
| Pubmed | Reduced expression of PDGF and PDGF receptors during impaired wound healing. | 2.64e-06 | 2 | 57 | 2 | 9242497 | |
| Pubmed | High-fat diet-induced obesity and insulin resistance in CYP4a14-/- mice is mediated by 20-HETE. | 2.64e-06 | 2 | 57 | 2 | 30088983 | |
| Pubmed | Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. | 2.64e-06 | 2 | 57 | 2 | 19208908 | |
| Pubmed | Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor. | 7.91e-06 | 3 | 57 | 2 | 27881889 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 35508129 | ||
| Pubmed | Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice. | 7.91e-06 | 3 | 57 | 2 | 2354437 | |
| Pubmed | Embryonic mouse testis development: role of platelet derived growth factor (PDGF-BB). | 7.91e-06 | 3 | 57 | 2 | 15254974 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 21574155 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 23146028 | ||
| Pubmed | CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane. | 7.91e-06 | 3 | 57 | 2 | 25637021 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 29380207 | ||
| Pubmed | CYP1A1, CYP2E1 and EPHX1 polymorphisms in sporadic colorectal neoplasms. | 7.91e-06 | 3 | 57 | 2 | 28018104 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 11124296 | ||
| Pubmed | Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas. | 7.91e-06 | 3 | 57 | 2 | 17298867 | |
| Pubmed | Conservation in sequence and affinity of human and rodent PDGF ligands and receptors. | 7.91e-06 | 3 | 57 | 2 | 8318539 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 17908297 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 21590454 | ||
| Pubmed | Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. | 7.91e-06 | 3 | 57 | 2 | 28270609 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 23567961 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 24530354 | ||
| Pubmed | Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors. | 7.91e-06 | 3 | 57 | 2 | 18492696 | |
| Pubmed | PDGFR-β Plays a Key Role in the Ectopic Migration of Neuroblasts in Cerebral Stroke. | 7.91e-06 | 3 | 57 | 2 | 26435273 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15791568 | ||
| Pubmed | Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. | 7.91e-06 | 3 | 57 | 2 | 9211853 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 16971512 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 24913005 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 37659685 | ||
| Pubmed | Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling. | 7.91e-06 | 3 | 57 | 2 | 21310211 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.02e-04 | 10 | 39 | 2 | 830 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_500 | 1.73e-06 | 144 | 54 | 6 | gudmap_kidney_adult_CortVasc_Tie2_k4_500 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.41e-05 | 314 | 54 | 7 | gudmap_kidney_adult_CortVasc_Tie2_k1_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_200 | 4.18e-05 | 76 | 54 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_k1_200 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_200 | 5.68e-05 | 162 | 54 | 5 | gudmap_kidney_adult_JuxtaGlom_Ren1_200 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 6.60e-05 | 400 | 54 | 7 | gudmap_kidney_adult_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_500 | 7.24e-05 | 406 | 54 | 7 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_500 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_top-relative-expression-ranked_500 | 8.56e-05 | 417 | 54 | 7 | gudmap_kidney_adult_CortVasc_Tie2_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.21e-04 | 441 | 54 | 7 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_1000 | EPHX1 SLC12A3 TCN2 PDGFRB CYP4A11 AASS GLB1L SLC6A19 CYP4A22 | 1.38e-04 | 778 | 54 | 9 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 1.68e-04 | 799 | 54 | 9 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.25e-04 | 831 | 54 | 9 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_k1_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_1000 | 2.93e-04 | 861 | 54 | 9 | gudmap_kidney_adult_RenalCortexMixed_Std_1000 | |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_top-relative-expression-ranked_1000 | 3.65e-04 | 887 | 54 | 9 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_1000 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.46e-08 | 174 | 57 | 6 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.13e-06 | 187 | 57 | 5 | f0c4d93f75615e570e4465fd622e3124189618a1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.13e-06 | 187 | 57 | 5 | 3ff57da09ed8394913fb683669d7bff84a936623 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-06 | 198 | 57 | 5 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 5.46e-06 | 198 | 57 | 5 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-06 | 199 | 57 | 5 | 6139687a3a5025cb98da4dba0183f95fcae3dc61 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-06 | 200 | 57 | 5 | c5d818203bef80ff97c2e0158cf61970673dd258 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.88e-05 | 157 | 57 | 4 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 160 | 57 | 4 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 162 | 57 | 4 | 3a61eda548afa2a41bdf6293d1050103dc210e52 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 162 | 57 | 4 | 593939be9d38690c89c31d4c58e351de26cbf9ab | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 168 | 57 | 4 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 168 | 57 | 4 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-05 | 169 | 57 | 4 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-05 | 169 | 57 | 4 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 173 | 57 | 4 | a37f38478473290fe35aea8684befc3bf95b161f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.27e-05 | 174 | 57 | 4 | 7fb7bdf62563f2102fb38618b503eb2817b6594f | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 175 | 57 | 4 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 8.47e-05 | 181 | 57 | 4 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-05 | 181 | 57 | 4 | bec7076efe94898213a62db72d171d737949977e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.47e-05 | 181 | 57 | 4 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-05 | 181 | 57 | 4 | cf149b30b814cf87c9e923ef502cadf7fe4a3597 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.47e-05 | 181 | 57 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.47e-05 | 181 | 57 | 4 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-05 | 183 | 57 | 4 | 01e7256c9e0ce53f8e10f3d3a5be15dedd312426 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.03e-05 | 184 | 57 | 4 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-05 | 186 | 57 | 4 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-05 | 188 | 57 | 4 | b483b4629695764568bcbd1d527d614824147783 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-05 | 188 | 57 | 4 | c1f64311ff05093b2f4f672e33f5f75e3bc8a8db | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 189 | 57 | 4 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 189 | 57 | 4 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 189 | 57 | 4 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 190 | 57 | 4 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | (09)_Interm._secr.>cil.-(0)_Reference|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.04e-04 | 191 | 57 | 4 | e63432718d62d39165ba8a66e14bb38c93907ffe | |
| ToppCell | facs-Aorta-Heart-18m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 191 | 57 | 4 | 6242f83acaf1714e9c1771a832cb67674b19e96d | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 192 | 57 | 4 | 9479e9859140ba98abfe88414de0b28fc2bf43b7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 193 | 57 | 4 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.09e-04 | 193 | 57 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 193 | 57 | 4 | fe9720185929ef849edd1b8eb4854306b392e5a2 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 194 | 57 | 4 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 194 | 57 | 4 | 7826fe5eb254ac032de0d978f39585a40e0b3ee4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 195 | 57 | 4 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-04 | 196 | 57 | 4 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 196 | 57 | 4 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 196 | 57 | 4 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 196 | 57 | 4 | 4ebcaac758ed01d918de9c1cd383a84457b615f3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 196 | 57 | 4 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | proximal-mesenchymal-Myofibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-04 | 197 | 57 | 4 | ab21baea931ff134cf5a7ee369c091230988108b | |
| ToppCell | proximal-mesenchymal-Myofibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-04 | 197 | 57 | 4 | 15f2f169758a07143fc7d1bdb58d0b4d750a0be4 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-04 | 197 | 57 | 4 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | proximal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-04 | 197 | 57 | 4 | c59b64674fb4aaa945c1df7e4a9a3605c7cd2b75 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 198 | 57 | 4 | 0f4052a59c6bd89dab637d6ef1214460d6cbcf55 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.20e-04 | 198 | 57 | 4 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-04 | 198 | 57 | 4 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | Parenchyma_COVID-19|World / Sample group, Lineage and Cell type | 1.20e-04 | 198 | 57 | 4 | 45ab554e6d0399b3182f089a25b2adf96de1144b | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 199 | 57 | 4 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 199 | 57 | 4 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 199 | 57 | 4 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 199 | 57 | 4 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 199 | 57 | 4 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 199 | 57 | 4 | a697b3f0760e66bad8ea8d83cf6fea5934692c56 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 199 | 57 | 4 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.22e-04 | 199 | 57 | 4 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.22e-04 | 199 | 57 | 4 | cb3c04b91c8e8080137823b11c76ca0a2adda52d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 199 | 57 | 4 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 | |
| ToppCell | 368C-Fibroblasts|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 199 | 57 | 4 | dbf64b83e2dc311b68f299c3f306ee098efd664c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.22e-04 | 199 | 57 | 4 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 199 | 57 | 4 | 50abd20eb461927fde0ec5caae501d7f2277cf78 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 199 | 57 | 4 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 200 | 57 | 4 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-04 | 200 | 57 | 4 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 200 | 57 | 4 | 17ffdbc13332bd3ed1d54abcd7af20267dd4b234 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.24e-04 | 200 | 57 | 4 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 200 | 57 | 4 | fc3c4778841c4b8bac0afb458352614b2c460617 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 200 | 57 | 4 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 200 | 57 | 4 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-04 | 200 | 57 | 4 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 200 | 57 | 4 | 665df8391d2ebcfc6536318612f4992852b5e2b8 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.24e-04 | 200 | 57 | 4 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.24e-04 | 200 | 57 | 4 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | supra_basal_cell|World / shred by cell class for nasal brushing | 1.24e-04 | 200 | 57 | 4 | 542bdcec563644e01887fd85eb158b32db439b03 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.24e-04 | 200 | 57 | 4 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-04 | 200 | 57 | 4 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-04 | 200 | 57 | 4 | 0655328373d1b58828e141ddb0dcbb2cce10dc50 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 1.24e-04 | 200 | 57 | 4 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 200 | 57 | 4 | 6b48ddde83bc6c941d557844aa214d4d2c8e736d | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 1.24e-04 | 200 | 57 | 4 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | Sigmoid-T_cell-Tfh|T_cell / Region, Cell class and subclass | 1.24e-04 | 200 | 57 | 4 | dd7dcf25520f065bf0d33d589f3c176f63875dc9 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 200 | 57 | 4 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | mild-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-04 | 200 | 57 | 4 | ca0a08bf162c954f037a56aa0cbb8b5d7c6ffec0 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.24e-04 | 200 | 57 | 4 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-04 | 104 | 57 | 3 | 793cc94735f4339bb189d288972a90b38a8fa850 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-04 | 104 | 57 | 3 | b6208db091c802f32fa64b2ef6701df1c0e9ad8b | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-2|TCGA-Stomach / Sample_Type by Project: Shred V9 | 6.58e-04 | 133 | 57 | 3 | 2d9e0a29eb205a5c2c8afe2e944115ab40b22afe | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.72e-04 | 134 | 57 | 3 | 9e12aac8f42790c2f104dfd61c87aa99fc7925f1 | |
| ToppCell | (09)_Ionocytes|World / shred by cell type and Timepoint | 6.87e-04 | 135 | 57 | 3 | 237b9b646513ca6e4b754c0da95d24015b3661f7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-04 | 136 | 57 | 3 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 7.17e-04 | 137 | 57 | 3 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| Drug | nopol | 4.76e-06 | 14 | 55 | 3 | CID000031408 | |
| Drug | 3-pyridyl)urea | 5.73e-06 | 2 | 55 | 2 | CID000202697 | |
| Drug | isocurcumenol | 5.73e-06 | 2 | 55 | 2 | CID005255901 | |
| Drug | 4-nitrophenylurea | 5.73e-06 | 2 | 55 | 2 | CID000313520 | |
| Drug | 1,4-androstadiene-3,17-dione | 5.73e-06 | 2 | 55 | 2 | ctd:C006573 | |
| Drug | 5,7-Dmpq | 5.73e-06 | 2 | 55 | 2 | CID000003139 | |
| Drug | 3,3',4,4',5,5'-hexabromobiphenyl | 1.06e-05 | 18 | 55 | 3 | CID000104942 | |
| Drug | styrene oxide | 1.53e-05 | 62 | 55 | 4 | CID000007276 | |
| Drug | LS-64027 | 1.72e-05 | 3 | 55 | 2 | CID000167812 | |
| Drug | 6,7-dimethoxyquinoline | 1.72e-05 | 3 | 55 | 2 | CID010856252 | |
| Drug | Becaplermin | 1.72e-05 | 3 | 55 | 2 | DB00102 | |
| Drug | 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol | 1.72e-05 | 3 | 55 | 2 | ctd:C024024 | |
| Drug | AC1NSUA7 | 1.72e-05 | 3 | 55 | 2 | CID005316441 | |
| Drug | Trichloroepoxypropane | 1.72e-05 | 3 | 55 | 2 | ctd:D014239 | |
| Drug | sunitinib malate | 1.74e-05 | 64 | 55 | 4 | CID006456015 | |
| Drug | lauroyl-CoA | 2.21e-05 | 68 | 55 | 4 | CID000165436 | |
| Drug | sporostatin | 3.43e-05 | 4 | 55 | 2 | CID006444393 | |
| Drug | CT52923 | 3.43e-05 | 4 | 55 | 2 | ctd:C461979 | |
| Drug | pimeprofen | 5.09e-05 | 84 | 55 | 4 | CID000003673 | |
| Drug | AC1L1TNA | 5.17e-05 | 167 | 55 | 5 | CID000009711 | |
| Drug | glucopiericidin A | 5.70e-05 | 5 | 55 | 2 | CID006440812 | |
| Drug | diselenium | 5.70e-05 | 5 | 55 | 2 | CID006397996 | |
| Drug | SCH 13929 | 5.70e-05 | 5 | 55 | 2 | CID000127725 | |
| Drug | selenium chloride | 5.70e-05 | 5 | 55 | 2 | CID000066206 | |
| Drug | glucoerucin | 5.70e-05 | 5 | 55 | 2 | ctd:C119493 | |
| Drug | L -892 | 5.70e-05 | 5 | 55 | 2 | CID000089377 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 5.72e-05 | 31 | 55 | 3 | ctd:C017228 | |
| Drug | mephenytoin | 6.11e-05 | 88 | 55 | 4 | CID000004060 | |
| Drug | 14(15)-EpETrE | 6.39e-05 | 89 | 55 | 4 | CID000001431 | |
| Drug | hydroxyl radicals | EPHX1 CYP1A1 UBA7 PTPN13 CYP4A11 RASA4 AASS GLB1L GCKR MNAT1 CYP4A22 GGT7 | 6.85e-05 | 1341 | 55 | 12 | CID000000961 |
| Drug | AC1L1BEQ | 7.59e-05 | 93 | 55 | 4 | CID000001407 | |
| Drug | bis-amidinium derivative of hoechst 33258 | 7.59e-05 | 93 | 55 | 4 | CID000449422 | |
| Drug | benzylthiourea | 8.54e-05 | 6 | 55 | 2 | CID000737375 | |
| Drug | sulfur monochloride | 8.54e-05 | 6 | 55 | 2 | CID000024807 | |
| Drug | allylbenzene | 8.54e-05 | 6 | 55 | 2 | CID000009309 | |
| Drug | 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene | 9.00e-05 | 36 | 55 | 3 | ctd:C054919 | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.03e-04 | 193 | 55 | 5 | 3811_UP | |
| Drug | benzo(a)pyrene-DNA adduct | 1.19e-04 | 7 | 55 | 2 | ctd:C056612 | |
| Drug | glucoraphanin | 1.19e-04 | 7 | 55 | 2 | ctd:C119494 | |
| Drug | DEET | 1.33e-04 | 204 | 55 | 5 | ctd:D003671 | |
| Drug | 3,5,5-trimethylhexanoylferrocene | 1.33e-04 | 41 | 55 | 3 | ctd:C050224 | |
| Drug | Sunitinib | 1.59e-04 | 8 | 55 | 2 | DB01268 | |
| Drug | p-azidophenylglyoxal | 1.59e-04 | 8 | 55 | 2 | CID000125200 | |
| Drug | Imatinib | 1.59e-04 | 8 | 55 | 2 | DB00619 | |
| Drug | tyrphostin AG1296 | 1.65e-04 | 44 | 55 | 3 | CID000002049 | |
| Drug | epo906 | 1.67e-04 | 114 | 55 | 4 | CID000388945 | |
| Drug | naphthalene-1,2-dihydrodiol | 1.76e-04 | 45 | 55 | 3 | CID000000362 | |
| Drug | axitinib | 1.76e-04 | 45 | 55 | 3 | CID006450551 | |
| Drug | AC1L3VO5 | 1.79e-04 | 116 | 55 | 4 | CID000123015 | |
| Drug | AC1L1R04 | 2.01e-04 | 47 | 55 | 3 | CID000008439 | |
| Drug | teucrin A | 2.04e-04 | 9 | 55 | 2 | CID000159529 | |
| Drug | 9,10-epoxystearic acid | 2.04e-04 | 9 | 55 | 2 | CID000015868 | |
| Drug | 1-benzylimidazole | 2.14e-04 | 48 | 55 | 3 | CID000077918 | |
| Drug | Simazine | 2.14e-04 | 48 | 55 | 3 | ctd:D012839 | |
| Drug | 19-HETE | 2.27e-04 | 49 | 55 | 3 | CID006439528 | |
| Drug | MEHP | 2.41e-04 | 50 | 55 | 3 | CID000020393 | |
| Drug | 3,4-dioctylphthalic acid | 2.45e-04 | 126 | 55 | 4 | CID005743034 | |
| Drug | NSC529592 | 2.51e-04 | 234 | 55 | 5 | CID000014403 | |
| Drug | triciribine | 2.55e-04 | 10 | 55 | 2 | ctd:C023764 | |
| Drug | 6,7-dimethoxy-3-phenylquinoxaline | 2.55e-04 | 10 | 55 | 2 | ctd:C106250 | |
| Drug | DB289 | 2.55e-04 | 10 | 55 | 2 | CID005480200 | |
| Drug | NADP(H | 2.65e-04 | 527 | 55 | 7 | CID000000930 | |
| Drug | glutathione reduced | 2.87e-04 | 534 | 55 | 7 | CID000000745 | |
| Drug | 1-chlorohexane | 3.11e-04 | 11 | 55 | 2 | CID000010992 | |
| Drug | 2,3-dichlorobutane | 3.11e-04 | 11 | 55 | 2 | CID000024233 | |
| Drug | benzo(c)phenanthrene | 3.11e-04 | 11 | 55 | 2 | ctd:C002615 | |
| Drug | 6,7-dimethoxyquinazoline | 3.11e-04 | 11 | 55 | 2 | CID003031661 | |
| Drug | 8co-myristic Acid | 3.11e-04 | 11 | 55 | 2 | CID000454062 | |
| Disease | alcohol dehydrogenase [NADP(+)] measurement | 1.06e-05 | 3 | 56 | 2 | EFO_0021977 | |
| Disease | ribitol measurement | 3.52e-05 | 5 | 56 | 2 | EFO_0800143 | |
| Disease | oligohydramnios (biomarker_via_orthology) | 3.52e-05 | 5 | 56 | 2 | DOID:12215 (biomarker_via_orthology) | |
| Disease | mitochondrial myopathy (implicated_via_orthology) | 5.28e-05 | 6 | 56 | 2 | DOID:699 (implicated_via_orthology) | |
| Disease | X-14939 measurement | 5.28e-05 | 6 | 56 | 2 | EFO_0800747 | |
| Disease | end stage renal disease (is_implicated_in) | 6.56e-05 | 41 | 56 | 3 | DOID:783 (is_implicated_in) | |
| Disease | Tumoral calcinosis | 7.05e-05 | 42 | 56 | 3 | C0263628 | |
| Disease | Calcinosis | 7.05e-05 | 42 | 56 | 3 | C0006663 | |
| Disease | Microcalcification | 7.05e-05 | 42 | 56 | 3 | C0521174 | |
| Disease | hypertension (biomarker_via_orthology) | 7.16e-05 | 227 | 56 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement | 7.38e-05 | 7 | 56 | 2 | EFO_0004612, EFO_0600007 | |
| Disease | periodontitis (is_implicated_in) | 7.38e-05 | 7 | 56 | 2 | DOID:824 (is_implicated_in) | |
| Disease | Leydig cell tumor (is_marker_for) | 9.83e-05 | 8 | 56 | 2 | DOID:2696 (is_marker_for) | |
| Disease | creatinine measurement | 9.91e-05 | 995 | 56 | 9 | EFO_0004518 | |
| Disease | Atrophic | 1.58e-04 | 10 | 56 | 2 | C0333641 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.92e-04 | 11 | 56 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | multiple myeloma (is_implicated_in) | 1.95e-04 | 59 | 56 | 3 | DOID:9538 (is_implicated_in) | |
| Disease | Agammaglobulinemia | 2.31e-04 | 12 | 56 | 2 | C0001768 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 2.37e-04 | 63 | 56 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | myeloid leukemia (is_implicated_in) | 2.72e-04 | 13 | 56 | 2 | DOID:8692 (is_implicated_in) | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.10e-04 | 69 | 56 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | urinary bladder cancer (is_implicated_in) | 4.13e-04 | 76 | 56 | 3 | DOID:11054 (is_implicated_in) | |
| Disease | Parkinson's disease (is_implicated_in) | 4.13e-04 | 76 | 56 | 3 | DOID:14330 (is_implicated_in) | |
| Disease | pneumonia (is_implicated_in) | 4.17e-04 | 16 | 56 | 2 | DOID:552 (is_implicated_in) | |
| Disease | coffee consumption, cups of coffee per day measurement | 4.17e-04 | 16 | 56 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | erythritol measurement | 4.72e-04 | 17 | 56 | 2 | EFO_0021171 | |
| Disease | Sjogren's syndrome (is_implicated_in) | 5.31e-04 | 18 | 56 | 2 | DOID:12894 (is_implicated_in) | |
| Disease | lung adenocarcinoma (is_marker_for) | 5.73e-04 | 85 | 56 | 3 | DOID:3910 (is_marker_for) | |
| Disease | caffeine metabolite measurement | 5.93e-04 | 19 | 56 | 2 | EFO_0007872 | |
| Disease | diacylglycerol 34:1 measurement | 9.51e-04 | 24 | 56 | 2 | EFO_0010352 | |
| Disease | diacylglycerol 34:2 measurement | 1.03e-03 | 25 | 56 | 2 | EFO_0010353 | |
| Disease | Heart valve disease | 1.12e-03 | 26 | 56 | 2 | C0018824 | |
| Disease | Micronuclei, Chromosome-Defective | 1.12e-03 | 26 | 56 | 2 | C1449861 | |
| Disease | Micronuclei, Genotoxicant-Induced | 1.12e-03 | 26 | 56 | 2 | C1449862 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 1.20e-03 | 27 | 56 | 2 | DOID:8552 (is_marker_for) | |
| Disease | bilirubin measurement | 1.50e-03 | 442 | 56 | 5 | EFO_0004570 | |
| Disease | Intellectual Disability | 1.58e-03 | 447 | 56 | 5 | C3714756 | |
| Disease | coffee consumption | 1.69e-03 | 32 | 56 | 2 | EFO_0004330 | |
| Disease | Alcoholic Intoxication | 1.69e-03 | 32 | 56 | 2 | C0001969 | |
| Disease | Squamous cell carcinoma | 1.71e-03 | 124 | 56 | 3 | C0007137 | |
| Disease | Chronic Obstructive Airway Disease | 1.80e-03 | 33 | 56 | 2 | C0024117 | |
| Disease | Chronic Airflow Obstruction | 1.80e-03 | 33 | 56 | 2 | C1527303 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.87e-03 | 128 | 56 | 3 | DOID:4450 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSHPLVLGKHPLLSG | 516 | A8K979 | |
| KVLHPGLLAQVHMDL | 311 | Q7Z695 | |
| MNLVPLGGTQIHLHK | 236 | Q32M84 | |
| NILHGMGLRLLALGH | 161 | Q9UDR5 | |
| PKGIMVLLSIYGLHH | 406 | Q02928 | |
| ILELLGPISMNHGVH | 1811 | Q5JWR5 | |
| PLVHLLCHEVKLGMQ | 271 | O43374 | |
| IHDMLEHGGNKILPV | 131 | Q96M98 | |
| PLVHLLCHEVKLGMQ | 271 | C9J798 | |
| HMLTLGKNPHLALSR | 51 | P04798 | |
| IHLELLPNQGMLIKH | 646 | Q9NVR2 | |
| EHLFMLHGKSLTVIP | 316 | Q9H8H0 | |
| LHCNIMHKGVTGKIP | 96 | A0A2R8YFM6 | |
| KIMTHLGPHLNIVNL | 646 | P16234 | |
| LGKSANILMIPHPHL | 526 | O75140 | |
| NPGQLLQLGMHSLHL | 76 | Q8N6C7 | |
| HLGIGHLNVAAKPEM | 2241 | P46531 | |
| GIKMGQHISLAPIHK | 226 | P51948 | |
| LQPSLMSILGGVHHL | 276 | P61550 | |
| MSILGGVHHLLNLTQ | 281 | P61550 | |
| TLPLAGLGGLMHLKL | 436 | Q9HBX8 | |
| QLPTGMLLGDLDHLK | 61 | Q6ZVZ8 | |
| GVPGMVKGLHEAHQL | 231 | Q9UJ14 | |
| FGKHLSPIVHILMAD | 266 | Q8NGJ5 | |
| TPLLHPLVMGSLGKH | 261 | P39060 | |
| HMVLSLHQKLAGRGL | 351 | Q9ULK4 | |
| EISMALGHLHQKGII | 201 | P23443 | |
| PNHKLLVLASDGGLM | 321 | Q9BZA7 | |
| LLGLGQKHLVMGDIP | 46 | P49321 | |
| TGAHVLLGKILQNHM | 491 | Q14397 | |
| HGVLHLDIKPSNILM | 6581 | Q5VST9 | |
| GLLALMLHQTIQHDP | 631 | Q9P0U4 | |
| GIQLHKMIRLITHGL | 516 | Q04446 | |
| AQLVPSHVKGLHLNM | 236 | P07099 | |
| FLKLSLGLPGLGIHM | 61 | P15391 | |
| PKGIMVLLSIYGLHH | 406 | Q5TCH4 | |
| MLGPVTLHLVGHLLA | 371 | Q6UWU2 | |
| KHLARLGMHVIIAGN | 61 | Q8N5I4 | |
| IEPHALFLGIHGGKM | 76 | P18510 | |
| DDQGQHPLLKMLLHL | 531 | Q8WXE1 | |
| ELKIMSHLGPHLNVV | 651 | P09619 | |
| PIKLGDHLNSILLGM | 121 | Q12923 | |
| LMLHQLQASVPGIHK | 1086 | P56715 | |
| SIHPALKGLGLASML | 106 | Q695T7 | |
| LPLGVLMKGQHLHLE | 81 | P78395 | |
| LPSGIGAHQHLKTLL | 106 | Q9C0I9 | |
| EHLLTNMGLKLGPAL | 581 | Q96NU1 | |
| TMGIKHSLHLCPLVI | 256 | Q8IXM7 | |
| AGNLHSMIHVGLLLR | 151 | A6NMS3 | |
| HLMLKPILGPLHNSE | 531 | Q96KW2 | |
| MDSHLVEKLGQHLLP | 26 | P20062 | |
| VLLHTGQKMPLIGLG | 6 | P14550 | |
| LMLKHLQEALGLPAG | 46 | Q9Y240 | |
| KMAKVLRSAGHHLIP | 131 | Q9NQW7 | |
| QGHLPMVILLLQHGA | 126 | Q8IUH4 | |
| LTGMHAGQPKHLLLV | 521 | P98077 | |
| LVLMGVGSLTLHDPH | 51 | P41226 | |
| VHNLHGMPGVLGALL | 341 | Q9H310 | |
| LMICGHVLIGPHKQR | 671 | P55017 | |
| KQMGLHGLHLFRSPL | 146 | Q5VWN6 |